-
Necrostatin 2: Precise RIPK2 Kinase Inhibition in Necropt...
2026-03-13
Necrostatin 2 (Nec-2), a next-generation RIPK2 kinase inhibitor, empowers researchers to unravel programmed necrotic cell death with nanomolar precision. Its robust performance in apoptosis-resistant models and ischemic stroke research positions it as a gold-standard tool for dissecting necroptosis and optimizing advanced experimental workflows.
-
Z-VEID-FMK: Unraveling Caspase-6 Inhibition in Apoptosis ...
2026-03-12
Explore how Z-VEID-FMK, a potent irreversible caspase-6 inhibitor, empowers advanced apoptosis assays and caspase activity measurement in cancer and neurodegenerative disease research. This article uniquely connects caspase-6 inhibition to emerging programmed cell death pathways, offering new perspectives for experimental design.
-
I-BET-762: Selective BET Inhibitor for Inflammation and E...
2026-03-12
I-BET-762 is a potent, selective BET bromodomain inhibitor with nanomolar affinity, widely used in epigenetic regulation and inflammation research. Its robust selectivity and mechanistic profile make it a benchmark agent for studying transcriptional regulation and ferroptosis in preclinical cancer and inflammatory models.
-
Auranofin: Precision Thioredoxin Reductase Inhibitor for ...
2026-03-11
Auranofin is a highly selective small molecule thioredoxin reductase inhibitor that disrupts redox homeostasis and induces apoptosis, making it a powerful tool in cancer and antimicrobial research. Its documented radiosensitizing effects and robust benchmarking in cellular and animal models underscore its translational value. APExBIO’s Auranofin (SKU B7687) offers reproducible, quantitative results for advanced biomedical workflows.
-
A-1210477: Precision MCL-1 Inhibition for Cancer Research
2026-03-11
A-1210477 (MCL-1 inhibitor) delivers unmatched selectivity and potency for dissecting apoptosis pathways in MCL-1-dependent cancer models. This guide unpacks optimized protocols, advanced use-cases, and troubleshooting strategies—empowering researchers to probe the Bcl-2 family protein network with confidence.
-
Guanabenz Acetate: Unveiling Novel Paradigms in α2-Adrene...
2026-03-10
Explore how Guanabenz Acetate, a potent α2-adrenergic receptor agonist, uniquely illuminates the interplay between GPCR signaling and innate immune modulation. This article delivers advanced mechanistic insights and experimental strategies for neuroscience receptor research and viral pathogenesis studies.
-
X-Gal in Molecular Cloning: Mechanistic Precision & Next-...
2026-03-10
Discover how X-Gal, a premier chromogenic substrate for β-galactosidase, empowers advanced blue-white colony screening and gene reporter assays. This in-depth guide explores the biochemical nuances, emerging applications, and unique regulatory insights that set APExBIO's X-Gal apart in modern recombinant DNA technology.
-
Artesunate: A Ferroptosis Inducer for Advanced Cancer Res...
2026-03-09
Artesunate, a high-purity artemisinin derivative supplied by APExBIO, is a potent ferroptosis inducer and AKT/mTOR pathway inhibitor for advanced cancer research. Its sub-5 μM IC50 against small cell lung carcinoma and robust solubility in DMSO and ethanol underpin its value in in vitro oncology models.
-
E-64: Precision Cysteine Protease Inhibition for Mechanis...
2026-03-09
E-64, a gold-standard L-trans-epoxysuccinyl peptide cysteine protease inhibitor from APExBIO, empowers researchers with irreversible, nanomolar-range inhibition of papain-like and lysosomal proteases. Its robust solubility and reproducibility streamline workflows in cancer research, protease signaling pathway analysis, and mechanistic studies, making it indispensable for both in vitro and in vivo applications.
-
Catalpol: Natural Iridoid Glycoside for Neuroprotection R...
2026-03-08
Catalpol stands out as a multi-pathway modulator in neuroprotection, osteoporosis, and anti-inflammation research, offering robust, reproducible results across diverse animal models. Its unique inhibition of NF-κB and NLRP3 inflammasome pathways, coupled with TrkB activation, makes it indispensable for translational studies targeting cognitive impairment, postmenopausal osteoporosis, and depression.
-
SB 202190: Selective p38 MAPK Inhibition for Advanced Can...
2026-03-07
SB 202190 is a potent, selective ATP-competitive inhibitor of p38α and p38β MAP kinases, widely used in cancer and inflammation research. Its high specificity and cell permeability enable robust dissection of MAPK signaling pathways, making it an essential tool for apoptosis, proliferation, and neuroprotection assays.
-
Myriocin: Benchmark Serine Palmitoyltransferase Inhibitor...
2026-03-06
Myriocin is a selective serine palmitoyltransferase inhibitor with high potency in sphingolipid metabolism and cancer research. It provides reproducible results in vitro and in vivo, offering mechanistic clarity for cell cycle and metabolic regulation. This dossier summarizes its mechanism, benchmarks, and workflow integration for advanced research applications.
-
Biotin-tyramide: Advancing Proximity Labeling & Vesicular...
2026-03-06
Explore the unique capabilities of Biotin-tyramide in tyramide signal amplification for high-resolution proximity labeling and vesicular trafficking studies. This in-depth guide delivers advanced scientific insights and practical considerations for biological imaging and detection workflows.
-
Pemetrexed: Advanced Antifolate for Cancer Chemotherapy R...
2026-03-05
Pemetrexed (LY-231514) stands out as a multi-targeted antifolate antimetabolite, enabling precision disruption of nucleotide biosynthesis in both in vitro and in vivo cancer models. This guide delivers actionable workflows, troubleshooting insights, and advanced strategies for deploying pemetrexed in studies of chemoresistance, DNA repair, and combination therapy—all backed by high-purity supply from APExBIO.
-
PD98059: Advanced Insights into MEK Inhibition and MAPK/E...
2026-03-05
Explore the multifaceted scientific applications of the selective and reversible MEK inhibitor PD98059 in MAPK/ERK pathway research. This in-depth article delivers unique mechanistic analysis, translational perspectives, and advanced research strategies to empower cancer and neuroprotection studies.
407 records 22/28 page Previous Next First page 上5页 2122232425 下5页 Last page